Rossini, M <br/><br/>
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?  [electronic resource] 

 -  Reumatismo  Mar 2015 
 - 285-303 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0048-7449 
<br/><br/><label>Standard No.: </label>10.4081/reumatismo.2014.799  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Psoriatic--drug therapy<br/>Arthritis, Rheumatoid--drug therapy<br/>Humans<br/>Randomized Controlled Trials as Topic<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome